Hiroyuki Ohshiro

Title: Hiroyuki Ohshiro: Innovator in Dementia Treatment

Introduction

Hiroyuki Ohshiro is a notable inventor based in Aichi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of dementia. His innovative work has led to the development of a unique compound that holds promise for improving the lives of those affected by this condition.

Latest Patents

Hiroyuki Ohshiro holds a patent for "5-HT4 receptor agonists for the treatment of dementia." This invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof with 5-HT4 agonistic activities, which is useful in the treatment of dementia. The patent also includes a pharmaceutical composition for the treatment of dementia that comprises a therapeutically effective amount of the compound. Furthermore, it outlines a method for treating dementia in an animal subject, including mammals, by administering the compound.

Career Highlights

Throughout his career, Hiroyuki Ohshiro has worked with various companies, including Raqualia Pharma Inc. and Askat Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and research.

Collaborations

Hiroyuki has collaborated with notable colleagues such as Akiyoshi Fujiuchi and Yukinori Take. These partnerships have played a crucial role in advancing his research and development efforts.

Conclusion

Hiroyuki Ohshiro's contributions to the field of dementia treatment through his innovative patent demonstrate his commitment to improving healthcare. His work continues to inspire advancements in pharmaceutical research and development.